Kymera's top drug hunter leaves for Alexis Borisy's Curie.Bio; What’s done is Dunn: FDA neuroscience leader bows out
By day two of his job as CSO partner at Alexis Borisy’s new investment and biotech services firm, Chris De Savi had already gone …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
